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elayed Calf Muscle Phosphocreatine Recovery
fter Exercise Identifies Peripheral Arterial Disease
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harlottesville, Virginia; and Providence, Rhode Island
OBJECTIVES In this study we intend to characterize phosphocreatine (PCr) recovery kinetics with
phosphorus-31 (31P) magnetic resonance spectroscopy in symptomatic peripheral arterial
disease (PAD) patients compared with control subjects and determine the diagnostic value
and reproducibility of this parameter.
BACKGROUND Due to the inconsistent relationship between flow and function in PAD, novel techniques
focused on the end-organ are needed to assess disease severity and measure therapeutic
response.
METHODS Fourteen normal subjects (5 men, age 45  14 years) and 20 patients with mild-to-moderate
symptomatic PAD (12 men, age 67  10 years, mean ankle brachial index 0.62  0.13) were
studied. Subjects exercised one leg to exhaustion while supine in a 1.5-T magnetic resonance
scanner using a custom-built plantar flexion device. Surface coil-localized, free induction
decay acquisition localized to the mid-calf was used. Each 31P spectrum consisted of 25 signal
averages at a repetition time of 550 ms. The PCr recovery time constant was calculated by
monoexponential fit of PCr versus time, beginning at exercise completion.
RESULTS Median exercise time was 195.0 s in normal subjects and 162.5 s in PAD patients (p 0.06).
Despite shorter exercise times in patients, the median recovery time constant of PCr was
34.7 s in normal subjects and 91.0 s in PAD patients. Area under the receiver-operating
characteristic curve was 0.925  0.045. Test-retest reliability was excellent.
CONCLUSIONS The PCr recovery time constant is prolonged in patients with symptomatic PAD compared
with normal subjects. The method is reproducible and may be useful in the identification of
disease. Further study of this parameter’s ability to track response to therapy as well as its
prognostic capability is warranted. (J Am Coll Cardiol 2006;47:2289–95) © 2006 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.12.069American College of Cardiology Foundation
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aeripheral arterial disease (PAD) is a condition character-
zed by atherosclerotic obstruction of the arteries supplying
he lower limbs. While peripheral blood flow at rest may be
dequate to preserve tissue viability, there is insufficient flow
o meet increased metabolic demands with exercise. Cur-
ently, between 8 and 12 million Americans are affected by
AD, and the incidence is expected to rise as the population
ges (1). Aside from the increased risk of both cerebrovas-
ular and coronary events, PAD patients may experience
ain, diminished exercise capacity, and significant tissue
oss, with some ultimately requiring amputation (2). Despite
growing appreciation of its contribution to vascular mor-
idity and mortality, PAD remains a clinical entity that is
nderdiagnosed, undertreated, and understudied (3,4).
Modalities currently utilized for the diagnosis and study
f PAD have a number of well-recognized limitations (5,6).
lthough the presence of macrovascular atherosclerosis can
enerally be established, these tests provide little informa-
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Manuscript received September 23, 2005; revised manuscript received December
0, 2005, accepted December 30, 2005.ion on the downstream consequences of proximal arterial
bstruction. Furthermore, increasing evidence suggests that
actors intrinsic to skeletal muscle influence the physiologic
mpact of arterial insufficiency and may contribute to the
oor correlation observed between hemodynamic parame-
ers and peak functional capacity in many patients with
laudication (7–9). Because of the sometimes inconsistent
elationship between flow and function, diagnostic tech-
iques that focus on the skeletal muscle may be better suited
han conventional methods for characterizing disease sever-
ty, monitoring its progression, and objectively measuring
herapeutic response.
For over three decades, phosphorus-31 magnetic reso-
ance spectroscopy (31P MRS) has been utilized for the
on-invasive study of muscle metabolism. Through the
easure of high-energy phosphorylated compounds, insight
nto cellular energetics can be achieved with precision
10,11). Although the kinetics for a number of compounds
an be characterized, phosphocreatine (PCr) recovery after
xercise may be the most important parameter in patients
ith PAD. By relying on both the arterial oxygen supply
nd the tissue’s capacity to utilize substrate, measurements
f PCr regeneration incorporate many of the adaptive
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PCr Recovery Time in Peripheral Arterial Disease June 6, 2006:2289–95nd/or maladaptive cellular changes developed in response
o a chronic limitation in blood flow (12). The purpose of
his study was to examine the utility of magnetic resonance
pectroscopy for determining PCr recovery time constant
fter exercise in the magnetic resonance scanner in patients
ith established PAD as compared with normal subjects.
ETHODS
tudy population. Patients between the ages of 30 to 85
ears with symptoms of intermittent claudication without
ritical limb ischemia and an ankle brachial index (ABI)
etween 0.4 and 0.9 were eligible for this study. Normal
uman subjects without risk factors for atherosclerosis were
ecruited from the community to serve as control subjects. The
rotocol was approved by the Human Investigation Commit-
ee at the University of Virginia, and all participants signed
nformed consent.
1P MRS. 31P spectra were acquired with a Siemens Sonata
.5-T magnetic resonance scanner (Siemens Medical Solu-
ions, Erlangen, Germany) using a single-pulse, surface coil
ocalized, 512-ms free induction decay acquisition with the coil
entered on the mid-calf. A standard 31P surface coil in the
atient table was employed. A coil signal intensity profile
ith a phosphorus phantom demonstrated excellent signal
ithin 7 to 8 cm. This distance fully encompasses the
astrocnemius and soleus of the average patient’s calf, the
uscles worked during plantar flexion.
Siemens spectroscopy software on a Leonardo worksta-
ion (Siemens Medical Solutions) was used to estimate
elative concentrations of adenosine triphosphate (ATP),
Cr, and inorganic phosphate (Pi). Free induction decays
ere multiplied by an exponential with a time constant of
10 ms and zero-filled from 1,024 to 2,048 points before
ourier transformation. Phase and baseline corrections were
ade, followed by Lorentzian fitting and integration of the
pectral peaks. The PCr recovery time constant (R), which
haracterizes the PCr recovery time, was calculated by
onoexponential fit of the PCr levels versus time (begin-
ing at the end of exercise), using the equation: y  a (b 
t/R), where y is the fitted PCr level, t is the time after
essation of exercise, and a and b are the fitted relative levels
f the PCr recovery curve. Tissue pH was calculated from
he chemical shift between Pi and PCr () using the
Abbreviations and Acronyms
ABI  ankle brachial index
ATP  adenosine triphosphate
PAD  peripheral arterial disease
PCr  phosphocreatine
Pi  inorganic phosphate
31P MRS phosphorus-31 magnetic resonance
spectroscopy
ROC  receiver-operating characteristicollowing formula: PpH  6.77  log10   3.29/5.68  
rotocol. All subjects were placed supine in the magnetic
esonance scanner with the calf at the magnet isocenter.
onitoring of the electrocardiogram and blood pressure
as performed with an InVivo 3155MVS (Intermagnetics
ompanies, Orlando, Florida). After shimming to mini-
ize non-uniformity of the magnetic field, five baseline
pectra were acquired. A magnetic resonance image-
ompatible plantar flexion exercise device was then affixed to
he magnetic resonance table. The subject was instructed to
ush the pedal at a steady rate until exhaustion or limiting
ymptoms developed, exercising the calf muscles. After four
reparation pulses, 25 signal averages at a repetition time of
50 ms were acquired for a total acquisition time of 16 s per
pectrum. Two spectra were acquired before the end of
xercise, followed by the acquisition of 18 spectra com-
encing at the end of exercise. Three PAD patients and
ight normal subjects returned at 315  188 days after
nitial study for studies of test-retest reliability.
tatistical analysis. Subject characteristics were summa-
ized as mean and standard deviation for continuous vari-
bles, and by frequencies for other variables. Characteristics
ere compared between control subjects and patients using
tests for continuous variables and chi-square tests for other
ariables. Exercise times, PCr recovery time constant, pH,
nd PCr/ATP were summarized as median and 25th
ercentile and 75th percentile. The Wilcoxon rank sum test
as used to compare the centers of the PCR recovery times,
H, and PCr/ATP for patients versus control subjects. A
mooth binormal receiver-operating characteristic (ROC)
urve was estimated. Reproducibility was analyzed using the
ethod of Bland and Altman (13). Statistical analyses were
erformed in Splus 2000 Professional Release 2 (MathSoft,
nc., Cambridge, Massachusetts).
ESULTS
wenty patients (12 men) and 14 control subjects (5 men)
ere studied. Demographic characteristics are summarized
n Table 1. The patients were older than the control subjects
67  10 years vs. 45  14 years, respectively, p  0.0001).
aseline clinical characteristics of PAD patients are pro-
ided in Table 2. Among PAD patients, the average ABI
able 1. Characteristics of Subjects
Controls PAD Patients
(n  14) (n  20) p Value
ge 45  14 67  10 0.0001
ender
Male 5 (36%) 12 (60%)
Female 9 (64%) 8 (40%) 0.2958
ace
White 10 (71%) 19 (95%)
African American 2 (14%) 1 (5%)
Asian 2 (14%) 0 (0%) 0.1226AD  peripheral arterial disease.
w
w
s
u
c
f
a
a
p
0
(
w
t
(
(
d
d
0
g
0
e
0
a
c
t
s
s
p
r
A
t
p
s
c
o
t
s
c
t
s
P
a
l
c
i
p
o
t
t
9
d
t
c
f
p
c
t
c
s
T
I
1
1
1
1
1
1
1
1
1
1
2
T
1
1
1
1
1
1
1
1
1
1
2
C
I
S
2291JACC Vol. 47, No. 11, 2006 Isbell et al.
June 6, 2006:2289–95 PCr Recovery Time in Peripheral Arterial Diseaseas 0.62  0.13. Mean systolic blood pressure of patients
as 141  19 mm Hg. Results from non-invasive vascular
tudies are shown in Table 3. Eleven of the patients
nderwent X-ray angiography, and nine of these had
omplete occlusions of at least one vessel (six superficial
emoral, three posterior tibial, two anterior tibial, one iliac,
nd one common femoral) with extensive collateralization.
Median exercise time was 195.0 s in normal subjects (25th
nd 75th percentiles 161.2 and 333.8 s) and 162.5 s in PAD
atients (25th and 75th percentiles  138.8 and 183.8 s; p 
.06). Representative PCr spectra (Fig. 1) and recovery plots
Fig. 2) are shown. The median recovery time constant of PCr
as 34.7 s in the control subjects (25th and 75th percen-
iles  25.9 and 51.2 s) and 91.0 s in the PAD patients
25th and 75th percentiles  65.0 and 134.5 s; p  0.0001)
Fig. 3). A ROC curve was constructed to determine the
iscriminatory power of the PCr recovery time constant for
etecting PAD (Fig. 4). The area under the fitted curve was
.925  0.045.
The PCr/ATP ratios were similar between the two
roups both at rest (p  0.50) and at end exercise (p 
.54). The median pH measured at the completion of
xercise was 7.02 in PAD and 6.95 in control subjects (p 
.19). No significant correlation between PCr recovery time
nd age was detected within either subgroup (p  0.31 for
ontrol subjects and p  0.56 for PAD patients) or within
he entire cohort (p 0.12); PCr recovery time was also not
ignificantly correlated with exercise time, within either
ubgroup (p  0.27 for control subjects, p  0.71 for
able 2. Baseline Clinical Characteristics of PAD Patients
ID CAD Stroke DM Tobacco
SBP
(mm Hg) EF (%)
1 No No No Former 120 53
2 Yes Yes Yes Former 114 61
3 Yes Yes No Never 130 63
4 Yes Yes Yes Current 130 38
5 No No No Current 139 N/A
6 Yes No No Former 180 40
7 No No No Current 175 N/A
8 No No No Former 140 N/A
9 Yes Yes Yes Former 138 53
0 Yes No Yes Former 150 55
1 Yes No Yes Current 150 N/A
2 N/A N/A N/A Former 134 N/A
3 Yes No Yes Former 109 75
4 Yes No No Current 148 N/A
5 Yes No No Former 137 60
6 Yes No No Former 140 59
7 Yes No No Current 180 48
8 Yes Yes No Former 144 60
9 Yes No No Current 137 70
0 Yes Yes No Former 135 40
79% 32% 32% 5% Never 141  19 56  12
60% Former
35% Current
AD  coronary artery disease; DM  diabetes mellitus; EF  ejection fraction;
D  patient number; N/A  data not available; PAD  peripheral arterial disease;
BP  systolic blood pressure.atients) or within the entire cohort (p  0.17). No
A
Nelationship was observed between PCr recovery time and
BI based on linear regression analysis (p  0.68). Fur-
hermore, exercise time did not correlate with ABI in
atients (p  0.27).
Clinical follow-up was completed in 100% of PAD
ubjects at a mean of 435  93 days. One patient died of
ardiovascular complications after non-vascular surgery. Six
f the limbs studied required revascularization or amputa-
ion. Percutaneous revascularization was performed in two
ubjects and surgical revascularization in four. In all but two
ases, progressive worsening of claudication was the indica-
ion for intervention, with one experiencing an acute occlu-
ion and another recurrent infection and tissue loss. Median
Cr recovery was 121.0 s (25th and 75th percentiles  91.8
nd 220.0 s) in patients that died during follow-up or had
imbs that required surgery, angioplasty, or amputation
ompared with 71.9 s in survivors that did not require limb
ntervention (25th and 75th percentiles  51.0 and 112.8 s;
 0.057). For PAD patients in the highest 75th percentile
f PCr recovery kinetics (recovery time constant 118 s),
he relative risk of subsequent surgery, angioplasty, ampu-
ation, or death was 3.11 (95% confidence interval 0.98 to
.84). Median ABI was similar among PAD patients who
ied or had limbs that required revascularization or ampu-
ation (0.58; 25th and 75th percentiles  0.53 and 0.65)
ompared with survivors free from limb intervention during
ollow-up (0.60; 25th and 75th percentiles 0.52 and 0.69;
 NS).
Studies of test-retest reliability were performed in eight
ontrol patients and three PAD patients. The PCr recovery
ime constant was highly reproducible with an intraclass
orrelation coefficient r  0.9505. Bland-Altman analysis is
hown in Figure 5. One additional PAD subject (data not
able 3. Severity of PAD Based on Pulse Volume Recordings
D ABI Inflow Outflow Runoff
1 0.58 Mild Mild Mod
2 0.95 Mild Severe Mild
3 0.67 Mild Mild Mod
4 0.48 Normal Mild Severe
5 0.52 Mod Mod Severe
6 0.51 Mild Mild Severe
7 0.60 Mod Mod Severe
8 0.70 Mild Mild Mod
9 0.82 Normal Normal Severe
0 0.69 Mild Mild Severe
1 0.56 N/A N/A N/A
2 0.50 Mod Mod Mod
3 0.61 Mild Mod Mod
4 0.68 Mild Mod Severe
5 0.66 Normal Normal Severe
6 0.81 Mod Mod Mod
7 0.45 Mod Mod Mild
8 0.52 Mod Mod Mod
9 0.66 Mild Mild Severe
0 0.57 Mod Mod Severe
0.62  0.13BI  ankle brachial index; ID  patient identification number; Mod  moderate;
/A  data not available; PAD  peripheral arterial disease.
i
r
a
e
f
D
T
k
p
a
c
w
e
u
r
P
m
p
r
s
i
F
(
r
3
p
F
t
F
a
r PDE
2292 Isbell et al. JACC Vol. 47, No. 11, 2006
PCr Recovery Time in Peripheral Arterial Disease June 6, 2006:2289–95ncluded in analysis or Fig. 5) had undergone surgical
evascularization before a repeat study performed 226 days
fter the initial study. In addition to a near doubling of
xercise time (135 vs. 230 s), PCr recovery time improved
rom 273 s at baseline to 60 s after revascularization.
igure 2. Representative phosphocreatine (PCr) recovery plots in control
top) and peripheral arterial disease (bottom) subjects. Note the steeper
ecovery curve in the control subject. The PCr recovery time constant was
igure 1. Sequential phosphorous-31 spectra acquired after exercise in a sub
fter exercise are shown. Note the incremental increase in phosphocrea
egeneration in the skeletal muscle tissue. ATP  adenosine triphosphate;4.4 s in the control subject and 121.1 s in the peripheral arterial disease
atient.
l
iISCUSSION
here are four important findings in this study: 1) the
inetics of PCr recovery can be characterized at the com-
letion of exercise in the magnetic resonance environment
mong patients with PAD; 2) the PCr recovery time
onstant is prolonged in patients with symptomatic PAD
hen compared with normal individuals despite shorter
xercise times and similar post-exercise pH with an area
nder the ROC curve of 0.925; 3) PCr recovery time is
eproducible and may represent a parameter with which
AD patients can be both identified and followed; and 4) a
easure of post-exercise PCr recovery may identify PAD
atients at higher risk of death and/or clinical deterioration
equiring intervention at one year.
Non-invasive modalities employed for the diagnosis and
tudy of PAD have a number of recognized limitations,
ncluding inaccuracy among patients with aortoiliac disease,
igure 3. In this graph of phosphocreatine (PCr) recovery time constants,
he boxes extend from the 25th to the 75th percentile, and the horizontal
ith peripheral arterial disease. In this example the first three spectra (45 s)
PCr) and simultaneous decrease in inorganic phosphate reflecting PCr
 phosphodiester; Pi  inorganic phosphate; PME  phosphomonester.ject w
tine (ines depict the medians. The median PCr recovery time constant is longer
n peripheral arterial disease (PAD) patients.
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June 6, 2006:2289–95 PCr Recovery Time in Peripheral Arterial Diseaseiabetes mellitus, and collateralized territories (5,6). Heavily
alcified arteries alone account for normal ABI values in as
any as 1 in 20 PAD patients (14). Both X-ray angiography
nd magnetic resonance angiography are limited to visual-
zing the vascular lumen. With these techniques, macrovas-
ular abnormalities serve as a surrogate marker of tissue
schemia, largely ignoring adaptations in cellular metabo-
ism and within the microvasculature that develop during
he evolution of vascular insufficiency and influence end-
rgan response (12,15).
igure 4. Receiver-operating characteristic curve for phosphocreatine
PCr) recovery kinetics. The points shown are the observed data.Figure 5. Reproducibility analyzed usingExperimental evidence from histopathologic and clinical
tudies suggests that skeletal muscle is not a passive by-
tander during development of peripheral vascular obstruc-
ion. Cellular alterations in PAD are comparable to those in
ubjects with mitochondrial myopathies and include altered
itochondrial enzyme expression, accumulation of the in-
ermediates of oxidative metabolism, and mitochondrial
eoxyribonucleic acid damage (15,16). Both biochemical
nd ultrastructural changes may, in part, explain why revas-
ularization does not normalize measures of clinical perfor-
ance in many PAD patients (17). While some metabolic
hanges may be maladaptive, others, such as an increase in
itochondrial density and more efficient glycolytic metab-
lism (18), can lead to improvement in symptoms and
xercise capacity in the absence of revascularization and may
nderlie the benefit of physical training in PAD (19).
The major role of PCr in muscle metabolism is as a
ransport molecule and reservoir of high-energy phosphate
onds, the sole currency of cellular energetics (20). Phos-
hocreatine regeneration occurs exclusively within the mi-
ochondria, and, because this depends entirely on the cell’s
apacity for oxidative phosphorylation and oxygen supply
21), it represents an ideal parameter for detecting metabolic
vidence of tissue ischemia. Relationships between peak
xygen uptake, maximal oxygen consumption (VO2max), and
Cr recovery kinetics have been well documented (22,23).
In the present study, PCr recovery time clearly distin-
uished symptomatic PAD patients from normal control
ubjects. These findings are in accordance with other studies
hat have demonstrated delayed regeneration of PCr as a
eliable marker of arterial obstruction (12,17,24,25). Whenthe method of Bland and Altman.
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PCr Recovery Time in Peripheral Arterial Disease June 6, 2006:2289–95ompared with normal subjects in our study, there was an
pproximate three-fold increase in the recovery time con-
tant among patients. The area under the fitted curve of the
OC analysis is 0.925, demonstrating that PCr recovery
inetics could be employed to discriminate mild-to-
oderate symptomatic PAD patients from normal subjects.
The median pH at end exercise was 7.02 in PAD patients
nd 6.95 in control subjects (p  0.19). Hence, prolonga-
ion in PCr recovery was not the result of greater acidosis at
nd exercise among PAD patients. This is important as
issue pH can influence PCr recovery kinetics. Not only is
reatine kinase a pH-dependent enzyme (21), but as much
s 40% of cellular ATP may be consumed in ion pumping
eactions during significant acidosis (23). With this ATP no
onger available to facilitate PCr regeneration, recovery time
s prolonged. Furthermore, PCr/ATP ratios were similar at
oth rest and peak exercise suggesting that differences in
Cr recovery times were not the consequence of greater
nergy debt among PAD patients. Moreover, significant left
entricular systolic dysfunction was not responsible for
rolonged PCr recovery times.
During clinical follow-up, revascularization was per-
ormed on six patients, and one individual died. Although
nly a trend, our data suggest longer PCr recovery time
onstants among mild-to-moderate PAD at greater risk for
eath, subsequent limb revascularization, or amputation
p  0.057). This was most apparent among patients in the
ighest quartile of PCr recovery kinetics (relative risk 
.11). No such trend was noted between these relevant
linical events and the resting ABI. This lack of correlation
etween the ABI and clinical events may be due to inherent
nadequacies in the test itself as it evaluates primarily
acrovascular hemodynamics rather than true tissue perfu-
ion. Although an excellent tool for identifying PAD with a
ensitivity and specificity of 90% and 98%, respectively (26),
he ABI frequently fails to predict functional capacity,
uality of life, symptoms, and clinical deterioration among
he subgroup of patients with mild-to-moderate disease
14,27–29). A diagnostic tool capable of predicting clinical
eterioration or death among patients with mild-to-
oderate PAD would be invaluable, and, thus, the relation-
hip between PCr recovery kinetics and clinical outcomes
arrants further study.
In PAD patients undergoing angiography, there was a
igh incidence of complete vascular occlusion. With respect
o other clinical characteristics, subjects in our protocol had
high incidence of coronary artery disease, diabetes melli-
us, and tobacco use, making this group quite representative
f the PAD population. The high-risk nature of mild-to-
oderate PAD patients is reflected in the number of
ascular events (peripheral angioplasty, vascular bypass,
mputation, myocardial infarction, stroke, and vascular
eath) experienced during the clinical follow-up period (11
vents in nine patients).
tudy limitations. In order to optimize temporal resolu-
ion and retain adequate signal to measure both pH and iCr/ATP ratios, a surface-coil acquisition localized to the
id-calf was employed with the understanding that both
xercising and non-exercising muscle groups would be
ncorporated into the signal, which might result in the
nderestimation of PCr depletion in the most stressed
uscle groups (30). With the knowledge that PCr recovery
ime is the most relevant parameter and resolution of Pi and
TP peaks less important, echo-planar spectroscopic imag-
ng could be used to interrogate individual muscle groups
ith adequate temporal resolution to assess PCr recovery
inetics (31).
Baseline age and gender differences between control
ubjects and patients might account for differences in PCr
ecovery time. However, others have demonstrated a lack of
orrelation between age and PCr recovery time (32,33), and
o age-related differences were noted within the present
ohort. While age-related changes in muscle mass, fiber
ype, and even oxidative capacity have been reported (34), a
umber of studies have demonstrated that active muscle
erfusion remains intact among healthy older individuals
35,36). Hence, baseline differences in age may only be
elevant under conditions in which blood flow is minimally
erturbed (submaximal exercise) and mitochondrial func-
ion becomes the rate-limiting step in PCr regeneration
17). Also, age-related differences may have gone undetec-
ed because of our small sample size and non-selective
pectroscopic technique.
Another potential limitation is that exercise ABIs, which
ay correlate better with disease severity than resting
easures, were not performed. Total work and the rate and
egree of plantar flexion were not controlled in our protocol.
rolongation of PCr regeneration does not pinpoint the
evel of vascular obstruction in PAD patients and has been
escribed in other disease states where substrate supply may
e limited or a primary metabolic defect exists (37,38). For
xample, in heart failure patients, delayed PCr recovery has
een attributed to decreased mitochondrial volume and
mpaired oxidative metabolism rather than central hemody-
amic factors (37). Many of the PAD patients had coronary
rtery disease. Myocardial ischemia and/or left ventricular
ysfunction that may have developed during the exercise
rotocol could have confounded our results. However, no
atients experienced chest pain or other clinical events
uring the exercise protocol. Furthermore, mean resting
jection fraction was preserved among patients in whom it
as measured clinically before study (ejection fraction 56 
2%). With respect to clinical events, the sample size is too
mall to draw any definitive conclusions regarding the
rognostic power of PCr recovery kinetics.
uture directions. The 31P MRS has a number of poten-
ial applications in the PAD population. The relationship
etween PCr recovery kinetics and clinical events involving
he lower limbs deserves further exploration in a larger
ohort of patients. Investigation of asymptomatic patients
nd those who experience atypical symptoms may provide
nsight into the biochemical characteristics that distinguish
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June 6, 2006:2289–95 PCr Recovery Time in Peripheral Arterial Diseasehese groups. Whether differences in PCr recovery time
esult entirely from changes in tissue blood flow, alterations
n skeletal muscle at a cellular level, or a combination of
oth deserves further investigation. We are developing
agnetic resonance measures of perfusion to compare with
r add to spectroscopy in terms of their correlation, inter-
ependence, and prognostic value. Another promising ap-
lication of this technique is as a platform to study the
urgical, percutaneous, and medical interventions currently
mployed as well as the investigational therapies of the
uture.
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